Stifel Reiterates Buy Rating on Compass Therapeutics (CMPX)
Go back to Stifel Reiterates Buy Rating on Compass Therapeutics (CMPX)| (NASDAQ: CMPX) | Delayed: 1.24 -0.58 (31.87%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.82 | 52 Week High | $ | |||
| Open | $1.25 | 52 Week Low | $ | |||
| Day High | $1.44 | P/E | N/A | |||
| Day Low | $1.15 | EPS | $ | |||
| Volume | 27,127,178 | |||||
